PubRank

B Willems

Author PubWeight™ 58.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial. Gut 2000 2.55
2 Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 1999 1.91
3 Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin. J Virol 1990 1.61
4 Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology 2000 1.55
5 Isometric maximal and submaximal trunk extension at different flexed positions in standing. Triaxial torque output and EMG. Spine (Phila Pa 1976) 1993 1.45
6 Risk factors for acquisition of hepatitis C virus infection in blood donors: results of a case-control study. Gastroenterology 1999 1.31
7 Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates. J Med Virol 2000 1.31
8 Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial. Hepatology 1987 1.22
9 Identification of numerous hepatitis C virus genotypes in Montreal, Canada. J Clin Microbiol 1996 1.14
10 A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 1994 1.12
11 Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D. AIDS Res Hum Retroviruses 1995 1.10
12 Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 2001 1.09
13 Smokers can learn to influence their urge to smoke. Addict Behav 2000 1.09
14 Antigenic evidence of the presence of the aberrant HIV-1ant70 virus in Cameroon and Gabon. AIDS 1993 1.09
15 Biological and clinicopathological features associated with hepatitis C virus type 5 infections. J Hepatol 1996 1.04
16 Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses. J Infect Dis 1995 1.04
17 Modeling HIV transfer between dendritic cells and T cells: importance of HIV phenotype, dendritic cell-T cell contact and T-cell activation. AIDS 2000 1.00
18 Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study. Am J Gastroenterol 1999 0.98
19 Visual determinants of reduced performance on the Stroop color-word test in normal aging individuals. J Clin Exp Neuropsychol 2001 0.95
20 Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assay. J Virol Methods 1998 0.95
21 Use of the 5' noncoding region for genotyping hepatitis C virus. J Infect Dis 1994 0.95
22 Presinusoidal portal hypertension in non-alcoholic cirrhosis. Hepatology 1985 0.95
23 The urge to smoke depends on the expectation of smoking. Addiction 2002 0.94
24 Transjugular intrahepatic portacaval stent shunt as a rescue treatment for life-threatening variceal bleeding in a cirrhotic patient with severe liver failure. Am J Gastroenterol 1992 0.89
25 Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing. AIDS 1998 0.89
26 Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group O. J Med Virol 1997 0.89
27 Effect of methodology on detection of HIV-1/HIV-2 dual infections in Côte d'Ivoire. J Virol Methods 1994 0.88
28 Intrapatient variability of HIV type 1 group O ANT70 during a 10-year follow-up. AIDS Res Hum Retroviruses 1999 0.88
29 Interpatient genetic variability of HIV-1 group O. AIDS 1999 0.86
30 Virologic and serologic characteristics of a natural chimpanzee lentivirus infection. Virology 1995 0.84
31 The neutralization relationship of HIV type 1, HIV type 2, and SIVcpz is reflected in the genetic diversity that distinguishes them. AIDS Res Hum Retroviruses 1997 0.84
32 Surgical treatment of severe postshunt hepatic encephalopathy. World J Surg 1991 0.84
33 Longitudinal comparison of virus load parameters and CD8 T-cell suppressive capacity in two SIVcpz-infected chimpanzees. J Med Primatol 2001 0.84
34 Emergency portacaval shunt for variceal hemorrhage. A prospective study. Ann Surg 1987 0.83
35 Genetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturally. J Med Virol 2001 0.83
36 HIV type 1 C2V3 env diversity among Belgian individuals. AIDS Res Hum Retroviruses 1998 0.83
37 Lack of relationship between preoperative measures of the severity of cirrhosis and short-term survival after liver transplantation. Liver Transpl Surg 1997 0.82
38 Multiple routes to object matching from different viewpoints: mental rotation versus invariant features. Perception 2001 0.82
39 Differential diagnosis of HIV type 1 group O and M infection by polymerase chain reaction and PstI restriction analysis of the pol gene fragment. AIDS Res Hum Retroviruses 1998 0.81
40 Quantitative assessment of serum hepatitis B e antigen, IgM hepatitis B core antibody and HBV DNA in monitoring the response to treatment in patients with chronic hepatitis B. J Viral Hepat 1997 0.81
41 Biological phenotypes of HIV-1 subtypes A and B strains of diverse origins. J Med Virol 1995 0.81
42 Dendritic cells, exposed to primary, mixed phenotype HIV-1 isolates preferentially, but not exclusively, replicate CCR5-using clones. AIDS 2000 0.81
43 Systemic and hepatic hemodynamics after variceal hemorrhage: effects of propranolol and placebo. Gastroenterology 1987 0.81
44 Genetic variability of HIV type 1 in Bénin. AIDS Res Hum Retroviruses 1996 0.81
45 Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates. Pharmazie 2008 0.80
46 Whole-body vibration exposure: a comprehensive field study. Am Ind Hyg Assoc J 1994 0.80
47 Effect of propranolol on hepatic and systemic hemodynamics in dogs with chronic bile duct ligation. Hepatology 1986 0.80
48 Macrophage-tropism of HIV-1 isolates of different genetic subtypes. AIDS 1997 0.80
49 Inhibition of TNF-alpha production by pentoxifylline does not prevent endotoxin-induced decrease in serum IGF-I. J Endocrinol 2003 0.79
50 Cross-neutralizing antibodies to HIV-1ANT70 and HIV-1IIIB in sera of African and Belgian HIV-1-infected individuals. AIDS 1994 0.79
51 Evaluation of different V3 peptides in an enzyme immunoassay for specific HIV type 1 group O antibody detection. AIDS Res Hum Retroviruses 1998 0.78
52 Hepatitis C virus genotypes in patients and blood donors--Quebec. Can Commun Dis Rep 1995 0.78
53 Cefotaxime, desacetyl-cefotaxime, and bactericidal activity in spontaneous bacterial peritonitis. J Infect Dis 1999 0.78
54 Usefulness of a novel Caco-2 cell perfusion system II. Characterization of monolayer properties and peptidase activity. Pharmazie 2009 0.77
55 Severe cholestasis leads to vitamin D depletion without perturbing its C-25 hydroxylation in the dog. Hepatology 1988 0.76
56 The role of the centre of projection in the estimation of slant from texture of planar surfaces. Perception 2001 0.76
57 Increase in ventilatory response to CO2 following tracheostomy in obstructive sleep apnea. Bull Eur Physiopathol Respir 1980 0.76
58 Measles vaccination coverage in high-incidence areas of the Western Cape, following the mass vaccination campaign. S Afr Med J 2013 0.76
59 HIV-1 group O infection in Belgium. Acta Clin Belg 1995 0.76
60 The influence of haemodialysis and haemofiltration on the clearance of torasemide in renal failure. Eur J Clin Pharmacol 1986 0.76
61 Herpes simplex hepatitis after liver transplantation: case report and literature review. Transpl Infect Dis 2014 0.75
62 Choledocho-ureteral anastomosis in the rat, a new experimental model of long-term, total, internal bile diversion. J Hepatol 1994 0.75
63 Biomethane potential of agro-industrial substrates depends on the inoculum type. Commun Agric Appl Biol Sci 2013 0.75
64 Database analysis of injury patterns in an institution for developmental disabilities. J Occup Rehabil 1995 0.75
65 Isolated perfused cirrhotic human liver obtained from liver transplant patients: a feasibility study. Hepatology 1990 0.75
66 [Gastric amyloidosis in simulating a pseudotumor]. Gastroenterol Clin Biol 1997 0.75
67 [Cryptorchism and its surgical treatment]. Acta Urol Belg 1977 0.75
68 Intrahepatic pressure measurement: not an accurate reflection of portal vein pressure. Hepatology 1988 0.75
69 Pharmacokinetics of benzodiazepine antagonist Ro 15-1788 in cirrhotic patients with moderate or severe liver dysfunction. Hepatology 1989 0.75
70 [We have to closely follow cases of acute hepatitis B to be assured of a cure]. Union Med Can 1993 0.75
71 A case of giant cell hepatitis recurring after liver transplantation and treated with ribavirin. Can J Gastroenterol 2000 0.75
72 Spontaneously reversible extensive portal vein thrombosis after gallbladder puncture during transjugular liver biopsy. J Hepatol 1996 0.75
73 Fracture-separation of the distal humeral epiphysis. Acta Orthop Belg 1987 0.75
74 Antibodies to V3 loop peptides derived from chimpanzee lentiviruses and the divergent HIV-1ANT-70 isolate in human sera from different geographic regions. AIDS 1994 0.75
75 [Preliminary survey of human immunodeficiency virus 1, group O in Burundi]. Med Trop (Mars) 1995 0.75
76 The HIV-2 genotype and the HIV-1 syncytium-inducing phenotype are associated with a lower virus replication in dendritic cells. J Med Virol 2000 0.75
77 Infectious virus titer, replicative and syncytium-inducing capacity of human immunodeficiency virus type 1. J Med Virol 1995 0.75
78 The influence of two-dimensional stimulus properties in a reconstruction task with minimal information stimuli. Spat Vis 2000 0.75